![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.globenewswire.com//news-release/2024/02/14/2829038/0/en/Carrick-Therapeutics-Announces-First-Patient-Dosed-in-Phase-1b-2-Clinical-Trial-of-Samuraciclib-in-Combination-with-Vepdegestrant-in-Patients-with-Advanced-Breast-Cancer.html
https://www.globenewswire.com//news-release/2023/12/15/2797014/0/en/Carrick-Therapeutics-Announces-First-Patient-Dosed-in-Phase-2b-Clinical-Trial-of-Samuraciclib-in-Combination-with-Fulvestrant-in-Patients-with-Advanced-HR-HER2-Breast-Cancer.html
https://www.globenewswire.com//news-release/2023/10/18/2762408/0/en/Carrick-Therapeutics-Announces-First-Patient-Dosed-in-Phase-2-Clinical-Trial-of-Samuraciclib-in-Combination-with-Elacestrant-in-Patients-with-Advanced-Breast-Cancer.html
https://www.clinicaltrialsarena.com/news/carrick-therapeutics-menarini-breast-cancer/
https://www.clinicaltrialsarena.com/news/carrick-therapeutics-menarini-breast-cancer/
https://endpts.com/pfizer-backs-60m-infusion-into-carrick-teams-up-on-breast-cancer-treatment/